212 related articles for article (PubMed ID: 9517610)
1. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.
Lesprit P; Godeau B; Authier FJ; Soubrier M; Zuber M; Larroche C; Viard JP; Wechsler B; Gherardi R
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):907-11. PubMed ID: 9517610
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients.
Allam JS; Kennedy CC; Aksamit TR; Dispenzieri A
Chest; 2008 Apr; 133(4):969-74. PubMed ID: 18198255
[TBL] [Abstract][Full Text] [Related]
3. Acute arterial obliteration: a new feature of the POEMS syndrome?
Lesprit P; Authier FJ; Gherardi R; Bélec L; Paris D; Melliere D; Schaeffer A; Godeau B
Medicine (Baltimore); 1996 Jul; 75(4):226-32. PubMed ID: 8699962
[TBL] [Abstract][Full Text] [Related]
4. POEMS syndrome-related pulmonary hypertension is steroid-responsive.
Jouve P; Humbert M; Chauveheid MP; Jaïs X; Papo T
Respir Med; 2007 Feb; 101(2):353-5. PubMed ID: 16774822
[TBL] [Abstract][Full Text] [Related]
5. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome.
Niimi H; Arimura K; Jonosono M; Hashiguchi T; Kawabata M; Osame M; Kitajima I
Intern Med; 2000 Dec; 39(12):1101-4. PubMed ID: 11197800
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension associated with POEMS syndrome.
Ribadeau-Dumas S; Tillie-Leblond I; Rose C; Saulnier F; Wemeau JL; Hatron PY; Wallaert B
Eur Respir J; 1996 Aug; 9(8):1760-2. PubMed ID: 8866608
[TBL] [Abstract][Full Text] [Related]
7. [Pro-inflammatory cytokines: a pathogenic key of POEMS syndrome].
Gherardi RK; Authier FJ; Belec L
Rev Neurol (Paris); 1996 May; 152(5):409-12. PubMed ID: 8881441
[TBL] [Abstract][Full Text] [Related]
8. Systemic corticosteroids as first-line treatment in pulmonary hypertension associated with POEMS syndrome.
Rached S; Athanazio RA; Dias SA; Jardim C; Souza R
J Bras Pneumol; 2009 Aug; 35(8):804-8. PubMed ID: 19750334
[TBL] [Abstract][Full Text] [Related]
9. Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?
Paciocco G; Bossone E; Erba H; Rubenfire M
Can J Cardiol; 2000 Aug; 16(8):1007-12. PubMed ID: 10978936
[TBL] [Abstract][Full Text] [Related]
10. POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells.
Rose C; Zandecki M; Copin MC; Gosset P; Labalette M; Hatron PY; Jauberteau MO; Devulder B; Bauters F; Facon T
Leukemia; 1997 Aug; 11(8):1318-23. PubMed ID: 9264387
[TBL] [Abstract][Full Text] [Related]
11. A case of POEMS syndrome with high concentrations of interleukin-6 in pericardial fluid.
Shikama N; Isono A; Otsuka Y; Terano T; Hirai A
J Intern Med; 2001 Aug; 250(2):170-3. PubMed ID: 11489068
[TBL] [Abstract][Full Text] [Related]
12. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review of the literature.
Feinberg L; Temple D; de Marchena E; Patarca R; Mitrani A
Crit Rev Oncog; 1999; 10(4):293-302. PubMed ID: 10654928
[TBL] [Abstract][Full Text] [Related]
13. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.
Soubrier M; Sauron C; Souweine B; Larroche C; Wechsler B; Guillevin L; Piette JC; Rousset H; Deteix P
Am J Kidney Dis; 1999 Oct; 34(4):633-8. PubMed ID: 10516342
[TBL] [Abstract][Full Text] [Related]
14. POEMS syndrome with vascular lesions: a role for interleukin-1beta and interleukin-6 increase--a case report.
Bova G; Pasqui AL; Saletti M; Bruni F; Auteri A
Angiology; 1998 Nov; 49(11):937-40. PubMed ID: 9822051
[TBL] [Abstract][Full Text] [Related]
15. [POEMS syndrome: role and value of interleukin-6].
Andrès E; Courouau F; Kaltenbach G; Maloisel F; Imler M
Rev Med Interne; 1996; 17(2):145-9. PubMed ID: 8787086
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension and refractory heart failure in a patient with Crow-Fukase (POEMS) syndrome.
Yokokawa T; Nakazato K; Kanno Y; Mizukami H; Kobayashi A; Yoshihisa A; Takahashi H; Shichishima-Nakamura A; Ohkawara H; Noji H; Suzuki H; Saitoh S; Ogawa K; Hisa S; Takeishi Y
Intern Med; 2013; 52(10):1061-5. PubMed ID: 23676591
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.
Chandrashekaran S; Dispenzieri A; Cha SS; Kennedy CC
Respir Med; 2015 Jan; 109(1):122-30. PubMed ID: 25433952
[TBL] [Abstract][Full Text] [Related]
18. Arterial obliteration in POEMS syndrome: possible role of vascular endothelial growth factor.
Soubrier M; Guillon R; Dubost JJ; Serre AF; Ristori JM; Boyer L; Sauvezie B
J Rheumatol; 1998 Apr; 25(4):813-5. PubMed ID: 9558193
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome.
Gherardi RK; Bélec L; Fromont G; Divine M; Malapert D; Gaulard P; Degos JD
Blood; 1994 May; 83(9):2587-93. PubMed ID: 8167341
[TBL] [Abstract][Full Text] [Related]
20. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome.
Kaushik M; Pulido JS; Abreu R; Amselem L; Dispenzieri A
Ophthalmology; 2011 Apr; 118(4):778-82. PubMed ID: 21035860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
